Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 1 - 1 of 1 results for "Mohit Rawat"

Super funds to reap returns from $2.2bn biotech exit

RIDDHIMA TALWANI  |  TUESDAY, 7 JUL 2026
... medicines that improve patients' lives takes time, conviction and, of course capital," Myricx Bio chief executive Mohit Rawat said. " Brandon Capital recognised the potential of NMT inhibition early, and has been a highly supportive investor, enabling ...
PAGE:
1